| Ytd | 80.65% | |
| 1y | 17.48% |
| Open | 3.37 | Prev Close | 3.40 | Low | 3.36 | High | 3.40 | Mkt Cap | 30.60M |
| Vol | 74.41K | Avg Vol | 115.76K | EPS | -1.86 | P/E | N/A | Forward P/E | -1.20 |
| Beta | 1.22 | Short Ratio | 1.79 | Inst. Own | 9.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.32 | 200-d Avg | 3.23 | 1yr Est | 14.00 |
SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Lisata Therapeuti
Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent va
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-sta
Lisata Therapeutics shares surged premarket after Kuva Labs agreed to acquire the company for $4 per
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be
Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.49) per share which beat the anal
Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stag
Results to be presented at the AACR Special Conference in Cancer Research: Advances in Pancreatic Ca
HC Wainwright & Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:LSTA) wit
Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.54) per share which beat the anal
Brookline Capital maintains Lisata Therapeutics (NASDAQ:LSTA) with a Buy and raises the price targ
Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for
ASCEND comprises two dosing regimens of certepetide evaluated in two separate study arms enrolled se
Expanded alliance combines Lisata's drug development expertise with GATC's AI-powered Multio
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
On Tuesday, 164 companies achieved new lows for the year.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quart
OnFriday, 143 stocks hit new 52-week lows.
Thursday's session saw 329 companies set new 52-week lows.
On Wednesday, 115 stocks hit new 52-week lows.
Monday saw 196 companies set new 52-week lows.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings
On Wednesday, 283 companies set new 52-week lows.
On Monday, 160 companies hit new 52-week lows.
During Tuesday's session, 78 companies made new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12